Internal Medicine, Hematology & Oncology · Ames, IA
NPI
1104012996
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1111 Duff Avenue
Ames, IA, 50010
Phone (515) 239-4401
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.3M
333,972 services
Medicare patients, 2024
1,118
Average age 76
Drug cost, 2024
$5.4M
4,136 prescriptions
Company payments, 2024
$15
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Venkatesh K Rudrapatna was code J1439 (injection, ferric carboxymaltose, 1 mg), 37,500 times for 36 patients. In total Venkatesh K Rudrapatna billed 333,972 services in 216 codes, and Medicare paid $5.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-10.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 37,500 | 36 | $0.87 | $33K |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 33,720 | 13 | $0.38 | $13K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 28,250 | 23 | $42.49 | $1.2M |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 27,500 | 23 | $2.30 | $63K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 21,600 | 22 | $35.82 | $774K |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 20,100 | 12 | $0.21 | $4,157 |
| J9267 Injection, paclitaxel, 1 mg | Office | 16,230 | 18 | $0.08 | $1,286 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 15,750 | 27 | $0.10 | $1,531 |
| J0897 Injection, denosumab, 1 mg | Office | 11,760 | 63 | $19.72 | $232K |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 7,150 | 26 | $37.96 | $271K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 5,200 | 11 | $0.05 | $280 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,160 | 83 | $0.09 | $374 |
| 99213 Office E&M - Established | Office | 1,892 | 745 | $59.68 | $113K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,890 | 50 | $0.67 | $1,264 |
| 85025 Blood Count | Office | 1,746 | 505 | $7.60 | $13K |
By year: 2022 $6.3M for 401,863 services; 2023 $7.0M for 412,712 services; 2024 $5.3M for 333,972 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,746 | 505 | $7.60 | $13K |
| 80053 Clinical Chemistry | 1,730 | 507 | $10.34 | $18K |
| 36415 Venipuncture Blood Collection | 1,356 | 490 | $8.64 | $12K |
| 83615 Clinical Chemistry | 712 | 315 | $5.91 | $4,210 |
| 83735 Clinical Chemistry | 584 | 94 | $6.57 | $3,837 |
| 84165 Clinical Chemistry | 219 | 110 | $10.55 | $2,311 |
| 82728 Clinical Chemistry | 173 | 120 | $13.36 | $2,311 |
| 83540 Clinical Chemistry | 155 | 112 | $6.34 | $983 |
| 83550 Clinical Chemistry | 155 | 112 | $8.57 | $1,328 |
| 85610 Clinical Chemistry | 141 | 14 | $4.20 | $592 |
Medicare prescription drug claims, 2024
In 2024, the drug Venkatesh K Rudrapatna prescribed most often to Medicare patients was Anastrozole, with 231 prescriptions and refills. In total Venkatesh K Rudrapatna wrote 4,136 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 231 | 501 | 60 | $3,593 |
| Levothyroxine Sodium Generic | 157 | 279 | 31 | $1,073 |
| Gabapentin Generic | 155 | 234 | 37 | $2,658 |
| Acyclovir Generic | 150 | 258 | 39 | $2,081 |
| Eliquis Apixaban | 145 | 187 | 34 | $104K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 135 | 135 | 32 | $3,229 |
| Omeprazole Generic | 126 | 214 | 33 | $965 |
| Hydroxyurea Generic | 117 | 234 | 27 | $2,699 |
| Potassium Chloride Generic | 95 | 167 | 34 | $1,506 |
| Warfarin Sodium Generic | 92 | 121 | 12 | $357 |
| Prochlorperazine Maleate Generic | 91 | 91 | 51 | $531 |
| Furosemide Generic | 87 | 130 | 21 | $270 |
| Dexamethasone Generic | 87 | 105 | 42 | $1,280 |
| Ondansetron Hcl Generic | 78 | 78 | 41 | $578 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 78 | 131 | 27 | $340 |
Brand drugs: 600 claims; generic drugs: 3,536 claims; opioid claims: 363.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Venkatesh K Rudrapatna $15 ($15 in general payments such as food, travel and fees) from 2 companies. The largest payer was Aveo Pharmaceuticals, Inc. with $15.
| Company | Payments | Amount |
|---|---|---|
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.